Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: http://www.sciepub.com/journal/jcrt Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Go
Journal of Cancer Research and Treatment. 2014, 2(2), 28-40
DOI: 10.12691/jcrt-2-2-2
Open AccessArticle

Study of Immune Effector Cells in Leukoplakia and Oral Cancer

Birva V. Brahmbhatt1, and Hemangini H. Vora1

1Immunohistochemistry and Flowcytometry Division, Gujarat Cancer and Research Institute, Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India

Pub. Date: September 18, 2014

Cite this paper:
Birva V. Brahmbhatt and Hemangini H. Vora. Study of Immune Effector Cells in Leukoplakia and Oral Cancer. Journal of Cancer Research and Treatment. 2014; 2(2):28-40. doi: 10.12691/jcrt-2-2-2

Abstract

Aim: Immunosuppresion in oral squamous cell carcinoma (OSCC) is related to high degree of recurrence and believed to develop from premalignant lesion. Leukocytes especially T cell subsets are important in immune surveillance during malignant transformation. This study has been planned to observe changes in systemic immune response in premalignant and malignant oral lesions. Method: The proportions of Neutrophils, Monocytes, Lymphocytes, total T cells, T cell subsets including αβ/γδ T cells, Cytotoxic T cells, Helper T cells, Naive/ Effector/Memory T cells, Regulatory T cells and NK-T subpopulations were analysed in peripheral circulation of healthy donors (N= 49), Leukoplakia (N=20) and OSCC patients (N=100) by flowcytometry. Results: In comparison with healthy donors, decreased Lymphocytes, Naive Helper cells, NK T subpopulations and increased Effector cells were observed in Leukoplakia patients. Similarly, decreased Lymphocytes, NK T subpopulations and increased Neutrophils, Monocytes, Helper and Regulatory T cells were observed in OSCC patients as compared to healthy controls. Moreover, Lymphocytes were decreased and Regulatory T cells were increaed during the progression of Leukoplakia to OSCC. Further, in relation with clinicopathological parameters, Cytotoxic cells were found to be reduced with increasing histological grade. Also, Helper cells were found to be decreased in patients with tobacco and alcohol habit and also with increasing tumor size. Further, in univariate survival analysis, increased incidence of relapse was observed in patients with low γδ and NK T cells. In multivariate survival analysis, low γδ T cells emerged as poor prognosticator for disease free survival and high Regulatory T cells emerged as poor prognosticator for predicting overall survival. Conclusion: Altered systemic immune response was seen during malignant transformation and also found to be associated with patient’s survival. Thus, investigation of circulating Leukocyte and T cell subsets seems to be useful for predicting patient’s survival and to identify immunosuppressed patients who may be benefited with immunotherapy.

Keywords:
immunosuppresion OSCC T cells flowcytometry

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Epstein JB, Güneri P, et al. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg.2009; 17: 79-87.
 
[2]  Mehta FS, Pindborg JJ, Gupta PC, Daftary DK et al. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer.1969; 24: 832-49.
 
[3]  Singh M, Krishanappa R, Bagewadi A, Keluskar V, et al. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol. 2004; 40: 591-6.
 
[4]  Mehta FS, Hamner IE et al. Tobacco-Related Oral Mucosal Lesions and Conditions in India. A Guide for Dental Students, Dentists and Physicians, Bombay: Tata Institute of Fundamental Research; 1993.
 
[5]  Hathway B, Ferris RL, Gooding W, Whiteside et al, Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. Current Research in Head and Neck Cancer, 62: 2005; 161-172.
 
[6]  Kuss I, Hathaway B, Ferris R, et al. Decreased absolute count of T lymphocytes subsets and their relation to disease in squamous cell carcinoma of head and neck. Clin Cancer Res 2004; 10: 3755-3762.
 
[7]  Alhamarneh O, Agada F, Madden L, Stafford N, Greenman J, et al. Serum IL 10 and circulating CD4+CD25high Regulatory T cells numbers as predectors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. HEAD & NECK—2010.
 
[8]  Boucek J, Mrkvan T, Chovanec M, Kuchar M, Betka J, et al. Regulatory T cells and their prognostic value for patirnts with squamous cell carcinoma of the head and neck. J. Cell.Mol. Med.2010; 14: (1-2); 426-433.
 
[9]  Pilai MR, Balaram P, Abraham T, Nair NK et al. Lymphocyte populations in premalignant lesions and cancer of the oral cavity. Neoplasma, 1987; 34: (4); 69-479.
 
[10]  Lee JJ, Lin CL, Chen T HH, et al. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan. Int. J. Oral Maxillofac. Surg. 2010; 39: 806-814.
 
[11]  Zahorec R et al, Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2011; 102: 5-14.
 
[12]  Shankaran W, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNα and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 2001; 410: 1107-1111.
 
[13]  Penn I, Harris JP, et al, Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981; 91: 520-528.
 
[14]  Kaplan R, Morse B, Huebner K, et al. Cloning of three human tyrosine phospahatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: (18); 7000-4.
 
[15]  Charazinska Carewicz K, Ganowicz E, Krol M, Gorska R, et al. Assessment of the peripheral immunocompetent cells in patients with reticular and atrophic-erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105: (2); 202-205.
 
[16]  Johannisson A, Festin R, et al. Phenotype transition of CD4+ T cells from CD45 RA to CD45 RO is accompanied by cell activation and proliferation. Cytometry 1995; 19: 343-352.
 
[17]  Naguchi A, Kaneko T, Naitoh K, Saito M, Iwai K, Maekawa R, et al. Impaired and imbalanced immunological status assessed in advanced cancer patients and restoration of the T cell immune status by adoptive T cell immunotherapy. International Immunopharmacology 2014;18: (1); 90-97.
 
[18]  Turksma AW, HJ Bontkes H, van den Heuvel, TD de Gruijl, et al. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients. Oral Diseases 2013; 19: (6); 577-584.
 
[19]  Strauss L, Bergmann C, Gooding W, Johnson JT, Whiteside TL, The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clinical Cancer Research 2007; 13: (21); 6301-6311.
 
[20]  Bose A, Chakraborty T, Chakraborty K, Pal S, Baral R, et al. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients. Cancer Immun 2008; 8: 1-10.
 
[21]  Gasparoto TH, Malaspina TS, Benevides L, et al. Patients with oral squamous cell carcinoma are characterised by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunol Immunotherapy 2010; 59: 819-828.
 
[22]  Zou W, et al. Regulatory T cells, tumor immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295-307. PMID: 16557261.
 
[23]  Molling JW, Langius JA, Langendijk JA, Leemans CR, et al. Low levels of circulating invariant Natural killer T cells predicts poor clinical outcome in patients with Head and Neck Squamous Cell Carcinoma. Journal of Clinical Oncology 2007, 25: (7); 862-868.
 
[24]  Guebre-Xabier M, Yang S, Lin HZ, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 2000; 31: 633-640.
 
[25]  Li Z, Soloski MJ, Diehl AM, et al. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005; 42: 880-885.
 
[26]  Singh AK, Shukla NK, Das SN et al. Altered Invariant Natural Killer T cell Subsets and its Functions in Patients with Oral Squamous Cell Carcinoma. Scandinavian Journal of Immunology 2013; 78: (5); 468-477.
 
[27]  Molling JW, Kolgen W, van der Vliet HJ, Boomsma MF, et al. Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer 2005; 116: 87-93.
 
[28]  Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol 2001; 67: 4046-4050.
 
[29]  Kim JW, Tsukishiro T, Johnson JT, et al. Expression of pro-and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2004; 10: 5101-5110.
 
[30]  Chikamatsu K, Sakakura K, Whiteside TL, Furuya N. Relationships between Regulatory T cells and CD8+ Effector populations in patients with Squamous cell Carcinoma of Head and Neck. HEAD & NECK 2007.
 
[31]  Hoffmann TK, Dworacki G, Tsukishiro T, Meidenbauer N, Gooding W, et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res.2002; 8: 2553-2562.
 
[32]  Manchanda P, Sharma SC, Das SN et al. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma. Oral Diseases, 2006; 12: (5); 455-462.
 
[33]  Saxena RK, Choudhry V, Nath I, Das SN, Paranjape S, et al. Normal ranges of some select lymphocyte sub-populations in peripheral blood of normal healthy Indians. Current Science 2004; 86 (7); 969-975.
 
[34]  Batista AC, Costa NL, Oton-Leite AF, Mendonça EF, et al. Distinctive clinical and microscopic features of squamous cell carcinoma of oral cavity and lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;109: e74-79.
 
[35]  Massano J, Regateiro FS, Januario G, Ferreira A et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 206; 102: 67-76.
 
[36]  Zancope E, Costa NL, Junqueira-Kipnis AP, et al. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med 2010; 39: 162-167.
 
[37]  Mortaz E, Kraneveld AD, Smt JJ, Kool M, et al. Effect of cigarette smoke extract on dendritic cells and their impact on T cell proliferation. PLoS ONE 2009; 4 (3): e4946.
 
[38]  Millrud CR, Mansson KA, Uddman R, Bjornsson S, et al. The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One 2010; 7, e51120.
 
[39]  Schmidt H, Bastholt L, Geertsen P, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer, 2005; 93: 273-278.
 
[40]  Fogar P, Sperti C, Basso D, et al. Decreased total lymphocyte counts in pancreatic cancer: An index of adverse outcome. Pancreas 2006;32: 22-28.
 
[41]  Donskov F, von der Maase H et al. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 2006; 24: 1997-2005.
 
[42]  Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastasis. Eur J Surg Oncol 2008; 34: 55-60.
 
[43]  Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009; 58: 15-23.
 
[44]  Bas M, Bier H, Schirlau K, Hoffman FU, Scheckenbach K, et al.Gamma delta T cells in patients with Squamous cell carcinoma of the head and neck. Oral Oncol, 2006; 42: (7); 691-697.
 
[45]  Roden AC, Morice WG, Hanson CA, et al. (2008). Immunophenotypic attributes of benign peripheral blood γδ T Cells and conditions associated with their increase. Arch Pathol Lab Med 2008; 132: 1774-1780.
 
[46]  Gao Y, Yang W, Pan M, Scully E, Girardi M, et al. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 2003; 198: 433-42.
 
[47]  Urban EM, Chapoval AI, Pauza CD, et al. Repertoire development 6. and the control of cytotoxic/effector function in human gammadelta T cells. Clin Dev Immunol, 2010: ID 732893.
 
[48]  Nakajima J, Murakawa T, Fukami T, Goto S, Kaneko T et al. A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells. Eur J Cardiothorac Surg 2010; 37: 1191-1197.
 
[49]  Yamasaki K, Horiguchi S, Kurosaki M, Kunii N, Nagato K, Hanaoka H, et al. Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin Immunol 2011; 138 (3): 255-265.
 
[50]  Loose D, Signore A, Bonanno E et al. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biotherapy and Radiopharmaceuticals 2008; 23: (1) 25-33.
 
[51]  Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
 
[52]  Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J clin Invest 2005; 115: 3623-3633.